GE HealthCare Receives FDA Clearance of Allia IGS Pulse for Cardiac Imaging

The FDA has given GE HealthCare’s Allia IGS Pulse 510(k) clearance for cardiac imaging regardless of patient size.

With Allia IGS Pulse, clinicians are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. As part of its new image chain, the system features a monopolar x-ray tube used to capture images for interventional procedures, the company said.

The small footprint of the tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations.

The Allia IGS Pulse was introduced at the Transcatheter Cardiovascular Therapeutics 2023 conference last week.

To read the whole story, click here to subscribe.

Related Topics